Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kizaki, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yamato, K; Hashimoto, S; Imamura, T; Uchida, H; Okahashi, N; Koseki, T; Ishisaki, A; Kizaki, M; Miyazono, K; Ikeda, Y; Nishihara, T
      Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells

      ONCOGENE
    2. Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y
      A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

      LEUKEMIA
    3. Kizaki, M; Takayama, N; Kawai, Y; Okamoto, S; Ikeda, Y
      Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D-3

      AMERICAN JOURNAL OF HEMATOLOGY
    4. Takayama, N; Kizaki, M; Hida, T; Kinjo, K; Ikeda, Y
      Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia

      EXPERIMENTAL HEMATOLOGY
    5. Kobayashi, Y; Nakano, Y; Kizaki, M; Hoshikuma, K; Yokoo, Y; Kamiya, T
      Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist

      PLANTA MEDICA
    6. Matsushita, M; Ikeda, H; Kizaki, M; Okamoto, S; Ogasawara, M; Ikeda, Y; Kawakami, Y
      Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    7. Kinjo, K; Kizaki, M; Muto, A; Fukuchi, Y; Umezawa, A; Yamato, K; Nishihara, T; Hata, J; Ito, M; Ueyama, Y; Ikeda, Y
      Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice

      LEUKEMIA
    8. Yamato, K; Hashimoto, S; Okahashi, N; Ishisaki, A; Nonaka, K; Koseki, T; Kizaki, M; Ikeda, Y; Nishihara, T
      Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7

      EXPERIMENTAL CELL RESEARCH
    9. Kawamura, C; Kizaki, M; Yamato, K; Uchida, H; Fukuchi, Y; Hattori, Y; Koseki, T; Nishihara, T; Ikeda, Y
      Bone morphogenetic protein-2 induces apoptosis in human myeloma cells withmodulation of STAT3

      BLOOD
    10. Kizaki, M; Fukuchi, Y; Ikeda, Y
      A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    11. Fukuchi, Y; Miyakawa, Y; Kizaki, M; Umezawa, A; Shimamura, K; Kobayashi, K; Kuramochi, T; Hata, J; Ikeda, Y; Tamaoki, N; Nomura, T; Ueyama, Y; Ito, M
      Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice

      ANNALS OF HEMATOLOGY
    12. Yoshinari, M; Imaizumi, M; Sato, A; Minegishi, M; Fujii, K; Suzuki, H; Miura, T; Funato, T; Saito, T; Chikaoka, S; Rikiishi, T; Kizaki, M; Iinuma, K
      G-CSF induces apoptosis of a human acute promyelocytic leukemia cell line,UF-1: Possible involvement of Stat3 activation and altered Bax expression

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    13. Kinjo, K; Kizaki, M; Takayama, N; Michikawa, N; Oda, A; Okamoto, SI; Tahara, T; Kato, T; Miyazaki, H; Ikeda, Y
      Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment

      BRITISH JOURNAL OF HAEMATOLOGY
    14. Matsushita, H; Kizaki, M; Kobayashi, H; Muto, A; Ikeda, Y
      Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8

      BRITISH JOURNAL OF CANCER
    15. Muto, A; Kizaki, M; Yamato, K; Kawai, Y; Kamata-Matsushita, M; Ueno, H; Ohguchi, M; Nishihara, T; Koeffler, HP; Ikeda, Y
      1,25-dihydroxyvitamin D-3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1)

      BLOOD
    16. OHGUCHI M; YAMATO K; ISHIHARA Y; KOIDE M; UEDA N; OKAHASHI N; NOGUCHI T; KIZAKI M; IKEDA Y; SUGINO H; NISIHARA T
      ACTIVIN A REGULATES THE PRODUCTION OF MATURE INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HUMAN MONOCYTIC CELLS

      Journal of interferon & cytokine research
    17. SATO A; IMAIZUMI M; KIZAKI M; SAITO T; YOSHINARI M; SUZUKI H; IINUMA K
      9-CIS RETINOIC ACID-INDUCED DIFFERENTIATION AND APOPTOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA-CELL LINE, UF-1, WITH RESISTANCE TO ALL-TRANS-RETINOIC ACID

      Experimental hematology
    18. IMAIZUMI M; SATO A; KIZAKI M; SAITO T; YOSHINARI M; SUZUKI H; IINUMA K
      IMPAIRED LIGAND-DEPENDENT TRANSCRIPTIONAL ACTIVITY OF MUTANT PML RARACHIMERIC PROTEIN DETECTED IN ACUTE PROMYELOCYTIC LEUKEMIA WITH AN ACQUIRED-RESISTANCE TO ALL-TRANS-RETINOIC ACID/

      Experimental hematology
    19. UENO H; KIZAKI M; MATSUSHITA H; MUTO A; YAMATO K; NISHIHARA T; HIDA T; YOSHIMURA H; KOEFFLER HP; IKEDA Y
      A NOVEL RETINOIC ACID RECEPTOR (RAR)-SELECTIVE ANTAGONIST INHIBITS DIFFERENTIATION AND APOPTOSIS OF HL-60 CELLS - IMPLICATIONS OF RAR-ALPHA-MEDIATED SIGNALS IN MYELOID LEUKEMIC-CELLS

      Leukemia research
    20. FUKUCHI Y; KIZAKI M; KINJO K; AWAYA N; MUTO A; ITO M; KAWAI Y; UMEZAWA A; HATA J; UEYAMA Y; IKEDA Y
      ESTABLISHMENT OF A RETINOIC ACID-RESISTANT HUMAN ACUTE PROMYELOCYTIC LEUKEMIA (APL) MODEL IN HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (HGM CSF) TRANSGENIC SEVERE COMBINED IMMUNODEFICIENCY (SCID) MICE

      British Journal of Cancer
    21. MATSUSHITA H; KIZAKI M; KOBAYASHI H; UENO H; MUTO A; TAKAYAMA N; AWAYA N; KINJO K; HATTORI Y; IKEDA Y
      RESTORATION OF RETINOID SENSITIVITY BY MDR1 RIBOZYMES IN RETINOIC ACID-RESISTANT MYELOID LEUKEMIC-CELLS

      Blood
    22. Kizaki, M; Muto, A; Kinjo, K; Ueno, H; Ikeda, Y
      Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    23. KIZAKI M; UENO H; MATSUSHITA H; TAKAYAMA N; MUTO A; AWAYA N; IKEDA Y
      RETINOID RESISTANCE IN LEUKEMIC-CELLS

      Leukemia & lymphoma
    24. NAGAO K; KIKUCHI A; KAWAI Y; KIZAKI M; IKEDA Y; NISHIKAWA T
      SKIN INFILTRATION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Dermatology
    25. YAMATO K; KOSEKI T; OHGUCHI M; KIZAKI M; IKEDA Y; NISHIHARA T
      ACTIVIN A INDUCTION OF CELL-CYCLE ARREST INVOLVES MODULATION OF CYCLIN D2 AND P21(CIP1 WAF1) IN PLASMACYTIC CELLS/

      Molecular endocrinology
    26. YAGUCHI M; MIYAZAWA K; KATAGIRI T; NISHIMAKI J; KIZAKI M; TOHYAMA K; TOYAMA K
      VITAMIN-K2 AND ITS DERIVATIVES INDUCE APOPTOSIS IN LEUKEMIA-CELLS ANDENHANCE THE EFFECT OF ALL-TRANS-RETINOIC ACID

      Leukemia
    27. WATANABE R; MURATA M; TAKAYAMA N; TOKUHIRA M; KIZAKI M; OKAMOTO S; KAWAI Y; WATANABE K; MURAKAMI H; KIKUCHI M; NAKAMURA S; IKEDA Y
      LONG-TERM FOLLOW-UP OF HEMOSTATIC MOLECULAR MARKERS DURING REMISSION INDUCTION THERAPY WITH ALL-TRANS-RETINOIC ACID FOR ACUTE PROMYELOCYTICLEUKEMIA

      Thrombosis and haemostasis
    28. AWAYA N; UCHIDA H; KINJO K; MATSUSHITA H; KAMATA T; MUTO A; TAKAYAMA N; HATTORI Y; KIZAKI M; IKEDA Y
      A NOVEL MUTATION IN THE CYTOPLASMIC DOMAIN OF G-CSF RECEPTOR GENE IN MDS - RELATIONSHIP WITH THE PROLIFERATIVE RESPONSE TO G-CSF AND ITS TRANSFORMING POTENTIAL

      Blood
    29. YAGUCHI M; MIYAZAWA K; UCHIDA Y; KATAGIRI T; NISHIMAKI J; GOTOH A; KIZAKI M; TOYAMA K
      COMBINATION OF VITAMIN-K2 AND ALL-TRANS-RETINOIC ACID ENHANCES INDUCTION OF APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      Blood
    30. USUKI K; URABE A; TOJO A; MORIWAKI H; TSURUMI H; IKEDA Y; KIZAKI M; TOYAMA K; AIZAWA M; INAI K; MUTO Y; ASANO S; TAKAKU F
      DIFFERENTIATION EFFECT OF ACYCLIC RETINOID ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS

      Annals of hematology
    31. ISHIDA A; MIYAKAWA Y; TANOSAKI R; WAKUI M; UENO H; WATANABE R; AWAYA N; TAHARA T; KATO T; MIYAZAKI H; ODA A; KIZAKI M; OKAMOTO S; IKEDA Y
      CIRCULATING ENDOGENOUS THROMBOPOIETIN, INTERLEUKIN-3, INTERLEUKIN-6 AND INTERLEUKIN-11 LEVELS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROWTRANSPLANTATION

      International journal of hematology
    32. NAKAJIMA H; KIZAKI M; UENO H; MUTO A; TAKAYAMA N; MATSUSHITA H; SONODA A; IKEDA Y
      ALL-TRANS AND 9-CIS RETINOIC ACID ENHANCE 1,25-DIHYDROXYVITAMIN-D-3-INDUCED MONOCYTIC DIFFERENTIATION OF U937 CELLS

      Leukemia research
    33. MUTO A; MORI S; MATSUSHITA H; AWAYA N; UENO H; TAKAYAMA N; OKAMOTO S; KIZAKI M; IKEDA Y
      SERIAL QUANTIFICATION OF MINIMAL RESIDUAL DISEASE OF T(8-21) ACUTE MYELOGENOUS LEUKEMIA WITH RT-COMPETITIVE PCR ASSAY

      British Journal of Haematology
    34. KIZAKI M; MATSUSHITA H; TAKAYAMA N; MUTO A; UENO H; AWAYA N; KAWAI Y; ASOU H; KAMADA N; IKEDA Y
      ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL ACUTE PROMYELOCYTIC LEUKEMIA-CELL LINE (UF-1) WITH RETINOIC ACID-RESISTANT FEATURES

      Blood
    35. WATANABE R; MURATA M; TAKAYAMA N; TOKUHIRA M; YOKOYAMA K; MORIKI T; KIZAKI M; OKAMOTO S; KAWAI Y; WATANABE K; MURAKAMI H; KIKUCHI M; NAKAMURA S; IKEDA Y
      LONG-TERM FOLLOW-UP OF HEMOSTATIC MOLECULAR MARKERS DURING REMISSION INDUCTION THERAPY WITH ALL-TRANS-RETINOIC ACID FOR ACUTE PROMYELOCYTICLEUKEMIA

      Blood
    36. UENO H; KIZAKI M; TAKAYAMA N; MUTO A; AWAYA N; MATSUSHITA H; AMBO H; KINJO K; IKEDA Y
      RETINOIDS HAVE DIRECT EFFECTS ON MEGAKARYOPOIESIS AND DIFFERENTIATE AMEGAKARYOBLASTIC LEUKEMIA-CELL LINE IN COMBINATION WITH THROMBOPOIETIN

      Blood
    37. YAGUCHI M; MIYAZAWA K; KATAGIRI T; NISHIMAKI J; IWASE O; KIZAKI M; TOHYAMA K; TOYAMA K
      VITAMIN-K-2 AND ITS DERIVATIVES INDUCE APOPTOSIS IN LEUKEMIA-CELLS AND HAVE A SYNERGISTIC EFFECT WITH ALL-TRANS-RETINOIC

      Blood
    38. MUTO A; KIZAKI M; UENO H; YAMATO K; OHGUCHI M; NISHIHARA T; KAWAI Y; KOEFFLER HP; IKEDA Y
      1,25-DIHYDROXYVITAMIN-D3 INDUCES DIFFERENTIATION OF RETINOIC ACID-RESISTANT APL CELL-LINE (UF-1) VIA ACTIVATED CYCLINE-DEPENDENT KINASE INHIBITORS

      Blood
    39. MATSUSHITA H; KIZAKI M; KOBAYASHI H; TAKAYAMA N; UENO H; MUTO A; AWAYA N; KINJO K; IKEDA Y
      RECOVERY OF DRUG-SENSITIVITY IN RETINOIC ACID-RESISTANT LEUKEMIC-CELLS BY MDR1 RIBOZYMES

      Blood
    40. KIZAKI M; DAWSON MI; HEYMAN R; ELSTNER E; MOROSETTI R; PAKKALA S; CHEN DL; UENO H; CHAO WR; MORIKAWA M; IKEDA Y; HEBER D; PFAHL M; KOEFFLER HP
      EFFECTS OF NOVEL RETINOID X RECEPTOR-SELECTIVE LIGANDS ON MYELOID LEUKEMIC DIFFERENTIATION AND PROLIFERATION IN-VITRO

      Blood
    41. KIZAKI M; UENO H; YAMAZOE Y; SHIMADA M; TAKAYAMA N; MUTO A; MATSUSHITA H; NAKAJIMA H; MORIKAWA M; KOEFFLER HP; IKEDA Y
      MECHANISMS OF RETINOID RESISTANCE IN LEUKEMIC-CELLS - POSSIBLE ROLE OF CYTOCHROME-P450 AND P-GLYCOPROTEIN

      Blood
    42. MOROSETTI R; GRIGNANI F; LIBERATORE C; PELICCI PG; SCHILLER GJ; KIZAKI M; BARTRAM CR; MILLER CW; KOEFFLER HP
      INFREQUENT ALTERATIONS OF THE RAR-ALPHA GENE IN ACUTE MYELOGENOUS LEUKEMIAS, RETINOIC ACID-RESISTANT ACUTE PROMYELOCYTIC LEUKEMIAS, MYELODYSPLASTIC SYNDROMES, AND CELL-LINES

      Blood
    43. MORIKI T; MURATA M; KIZAKI M; KAWAI Y; WATANABE K; IKEDA Y
      ACUTE PROMYELOCYTIC LEUKEMIA DEVELOPED IN A PATIENT WITH CONGENITAL ANTITHROMBIN-III DEFICIENCY

      International journal of hematology
    44. MASUDA Y; KIZAKI M; UENO H; MORI S; TAKAYAMA N; MUTO A; MATSUSHITA H; IKEDA E; KAWAI Y; IKEDA Y
      CHRONIC MYELOGENOUS LEUKEMIA (CML) ASSOCIATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)-PRODUCING MESOTHELIOMA

      Leukemia
    45. UENO H; KIZAKI M; TAKAYAMA N; MATSUSHITA H; MUTO A; OKAMOTO S; IKEDA Y
      ITRACONAZOLE AND RETINOID RESISTANCE

      American journal of hematology
    46. WATANABE R; OKAMOTO S; MORIKI T; KIZAKI M; KAWAI Y; IKEDA Y
      TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ALL-TRANS-RETINOIC ACID DURING THE 3RD-TRIMESTER OF PREGNANCY

      American journal of hematology
    47. MORI S; MUTO A; UCHIDA H; WATANABE R; MATSUSHITA H; NAKAJIMA H; KIZAKI M; OKAMOTO S; KAWAI Y; INATOMI Y; WAKASUGI K; ABE T; IKEDA Y
      ESTABLISHMENT OF A NEW CELL-LINE CARRYING T(14-18) FROM NON-HODGKINS-LYMPHOMA

      Experimental hematology
    48. MORI S; MATSUSHITA H; OZAKI K; ISHIDA A; TOKUHIRA M; NAKAJIMA H; KIZAKI M; SUGIURA H; KIKUCHI A; HANDA M; KAWAI Y; YAMAMORI S; IKEDA Y
      SPONTANEOUS RESOLUTION OF TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE

      Transfusion
    49. KIZAKI M; TAKAYAMA N; MATSUSHITA H; UENO H; MUTO A; AWAYA N; KAWAI Y; IKEDA Y
      ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL ACUTE PROMYELOCYTIC LEUKEMIA-CELL LINE (UF-1) WITH RETINOIC ACID-RESISTANT FEATURES

      Blood
    50. MATSUSHITA H; KOBAYASHI H; MORI S; MUTO A; UENO H; TAKAYAMA N; AWAYA N; KIZAKI M; IKEDA Y
      RIBOZYMES CLEAVE AML1 MTG8 TRANSCRIPT AND INHIBIT THE PROLIFERATION OF LEUKEMIC-CELLS WITH T(8-21)/

      Blood
    51. MUTO A; MORI S; MATSUSHITA H; UENO H; TAKAYAMA N; KIZAKI M; IKEDA Y
      DEVELOPMENT AND CLINICAL-EVALUATION OF QUANTIFICATION OF THE MINIMAL RESIDUAL DISEASE IN T(8-21) LEUKEMIA WITH NOVEL RT-COMPETITIVE PCR ASSAY

      Blood
    52. MATSUSHITA H; KOBAYASHI H; MORI S; KIZAKI M; IKEDA Y
      RIBOZYMES CLEAVE THE AML1 MTG8 FUSION TRANSCRIPT AND INHIBIT PROLIFERATION OF LEUKEMIC-CELLS WITH T(8-21)/

      Biochemical and biophysical research communications
    53. KAWAI Y; WATANABE K; KIZAKI M; MURATA M; KAMATA T; UCHIDA H; MORIKI T; YOKOYAMA K; TOKUHIRA M; NAKAJIMA H; HANDA M; IKEDA Y
      RAPID IMPROVEMENT OF COAGULOPATHY BY ALL-TRANS-RETINOIC ACID IN ACUTEPROMYELOCYTIC LEUKEMIA

      American journal of hematology
    54. KIZAKI M; KOBAYASHI Y; IKEDA Y
      RAPID AND SENSITIVE DETECTION OF THE FEMA GENE IN STAPHYLOCOCCI BY ENZYMATIC DETECTION OF POLYMERASE CHAIN-REACTION (ED-PCR) - COMPARISON WITH STANDARD PCR ANALYSIS

      The Journal of hospital infection
    55. KOBAYASHI Y; KIZAKI M; KAWAKAMI Y; UCHIDA H; IKEDA Y
      ASSESSMENT OF THE ED-PCR METHOD FOR DETECTION OF THE MECA GENE OF STAPHYLOCOCCUS-AUREUS

      The Journal of hospital infection
    56. TANOSAKI R; OKAMOTO S; AKATSUKA N; ISHIDA A; MICHIKAWA N; MASUDA Y; UCHIDA H; MURATA M; KIZAKI M; IKEDA Y
      DOSE-ESCALATION OF BIWEEKLY CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISOLONE USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA

      Cancer
    57. DAWSON MI; ELSTNER E; KIZAKI M; CHEN DL; PAKKALA S; KERNER B; KOEFFLER HP
      MYELOID DIFFERENTIATION MEDIATED THROUGH RETINOIC ACID RECEPTOR RETINOIC-X RECEPTOR (RXR) NOT RXR RXR PATHWAY/

      Blood
    58. NAKAJIMA H; KIZAKI M; SONODA A; MORI S; HARIGAYA K; IKEDA Y
      RETINOIDS (ALL-TRANS AND 9-CIS RETINOIC ACID) STIMULATE PRODUCTION OFMACROPHAGE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY HUMAN BONE-MARROW STROMAL CELLS

      Blood
    59. NAKAJIMA H; KIZAKI M; UENO H; MUTO A; MATSUSHITA H; IKEDA Y
      DIFFERENTIATION OF U937 CELLS BY VITAMIN-D3 IS ENHANCED BY RETINOIC ACIDS AND OLIGONUCLEOTIDES FOR VITAMIN-D3 RESPONSIVE ELEMENTS

      Blood
    60. KIZAKI M; UENO H; TAKAYAMA N; NAKAJIMA H; MORIKAWA M; YAMAZOE Y; KOEFFLER HP; IKEDA Y
      MECHANISMS OF RETINOID RESISTANCE IN LEUKEMIC-CELLS - ROLE OF CYTOCHROME-P-450 AND P-GLYCOPROTEIN

      Blood
    61. KIZAKI M; MILLER CW; SELSTED ME; KOEFFLER HP
      MYELOPEROXIDASE (MPO) GENE MUTATION IN HEREDITARY MPO DEFICIENCY

      Blood
    62. KIZAKI M; NAKAJIMA H; MORI S; KOIKE T; MORIKAWA M; OHTA M; SAITO M; KOEFFLER HP; IKEDA Y
      NOVEL RETINOIC ACID, 9-CIS RETINOIC ACID, IN COMBINATION WITH ALL-TRANS-RETINOIC ACID IS AN EFFECTIVE INDUCER OF DIFFERENTIATION OF RETINOIC ACID-RESISTANT HL-60 CELLS

      Blood
    63. KIZAKI M; IKEDA Y; SIMON KJ; NANJO M; KOEFFLER HP
      EFFECT OF 1,25-DIHYDROXYVITAMIN-D(3) AND ITS ANALOGS ON HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN MONOCYTES MACROPHAGES

      Leukemia
    64. KOBAYASHI Y; KIZAKI M; KAWAKAMI Y; UCHIDA H; IKEDA Y
      ASSESSMENT OF OXACILLIN SALT AGAR FOR DETECTION OF MRSA IDENTIFIED BYPRESENCE OF THE MECA GENE

      The Journal of hospital infection
    65. PAQUETTE RL; LEE YY; WILCZYNSKI SP; KARMAKAR A; KIZAKI M; MILLER CW; KOEFFLER HP
      MUTATIONS OF P53 AND HUMAN PAPILLOMAVIRUS INFECTION IN CERVICAL-CARCINOMA

      Cancer
    66. KIZAKI M; SAKASHITA A; KARMAKAR A; LIN CW; KOEFFLER HP
      REGULATION OF MANGANESE SUPEROXIDE-DISMUTASE AND OTHER ANTIOXIDANT GENES IN NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS AND THEIR RELATIONSHIP TO CYTOTOXICITY BY TUMOR-NECROSIS-FACTOR

      Blood
    67. KIZAKI M; IKEDA Y; TANOSAKI R; NAKAJIMA H; MORIKAWA M; SAKASHITA A; KOEFFLER HP
      EFFECTS OF NOVEL RETINOIC ACID COMPOUND, 9-CIS-RETINOIC ACID, ON PROLIFERATION, DIFFERENTIATION, AND EXPRESSION OF RETINOIC ACID RECEPTOR-ALPHA AND RETINOID-X RECEPTOR-ALPHA RNA BY HL-60 CELLS

      Blood
    68. NAKAJIMA H; KIZAKI M; MORI S; HARIGAYA K; IKEDA Y
      EFFECTS OF RETINOIC ACID COMPOUNDS(ALL-TRANS AND 9-CIS RETINOIC ACID)ON CYTOKINE PRODUCTION AND EXPRESSION OF RAR AND RXR GENES BY HUMAN BONE-MARROW STROMAL CELLS

      Blood
    69. KIZAKI M; IKEDA Y; NAKAJIMA H; MORI S; MORIKAWA M; OHTA M; SAITO M; KOEFFLER H
      NOVEL RETINOIC ACID, 9-CIS RETINOIC ACID, IN COMBINATION WITH ALL-TRANS-RETINOIC ACID IS EFFECTIVE INDUCER OF DIFFERENTIATION OF RETINOIC ACID-RESISTANT HL-60 CELLS - RELATION TO RETINOIC ACID RECEPTOR AND RETINOID X-RECEPTOR EXPRESSION

      Blood
    70. MORI S; MATSUSHITA H; OZAKI K; ISHIDA A; TOKUHIRA M; NAKAJIMA H; KIZAKI M; HANDA M; KAWAI Y; OKAMOTO S; YAMAMORI T; IKEDA Y
      ATYPICAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE - DEMONSTRATION OF Y-CHROMOSOME SPECIFIC GENES IN THE SKIN BY PCR

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 21:57:46